Brief: Medesis Pharma H1 Net Loss Widens To 1.1 Million Euros
Sept 16 (Reuters) - MEDESIS PHARMA SA ALMDP.PA :
* H1 NET REVENUE EUR 73,050 VERSUS NO REVENUE YEAR AGO
* H1 OPERATING LOSS EUR 1.4 MILLION VERSUS LOSS EUR 1.0
MILLION
YEAR AGO
* H1 NET LOSS EUR 1.1 MILLION VERSUS LOSS EUR 0.8 MILLION
YEAR AGO
Further company coverage: ALMDP.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Medesis Pharma SA
See all newsBrief: Medesis Pharma FY EBIT Loss Widens To EUR 3.244 Mln
Brief: Medesis Pharma Signs A Partnership With Partner International
Brief: Medesis Pharma Issues Bond Financing With Maximum Potential Nominal Amount Of EUR 2.5 Mln
Brief: Medesis Pharma Creates Council For Neurodegenerative Diseases
Brief: Medesis Pharma H1 Operating Loss Widens To 1.8 Million Euros